BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18412969)

  • 1. Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo.
    Liu L; Chavan R; Feinberg MB
    BMC Immunol; 2008 Apr; 9():15. PubMed ID: 18412969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.
    Chahroudi A; Garber DA; Reeves P; Liu L; Kalman D; Feinberg MB
    J Virol; 2006 Sep; 80(17):8469-81. PubMed ID: 16912297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses.
    Chavan R; Marfatia KA; An IC; Garber DA; Feinberg MB
    J Virol; 2006 Aug; 80(15):7676-87. PubMed ID: 16840346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Induction of Cytotoxic T Cells by Viral Vector Vaccination Requires STING-Dependent DC Functions.
    Barnowski C; Ciupka G; Tao R; Jin L; Busch DH; Tao S; Drexler I
    Front Immunol; 2020; 11():1458. PubMed ID: 32765505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.
    Guzman E; Cubillos-Zapata C; Cottingham MG; Gilbert SC; Prentice H; Charleston B; Hope JC
    J Virol; 2012 May; 86(10):5452-66. PubMed ID: 22419811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunity.
    Greiner S; Humrich JY; Thuman P; Sauter B; Schuler G; Jenne L
    Clin Exp Immunol; 2006 Nov; 146(2):344-53. PubMed ID: 17034588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene
    Chea LS; Wyatt LS; Gangadhara S; Moss B; Amara RR
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect.
    Brandler S; Lepelley A; Desdouits M; Guivel-Benhassine F; Ceccaldi PE; Lévy Y; Schwartz O; Moris A
    J Virol; 2010 May; 84(10):5314-28. PubMed ID: 20219934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
    Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
    J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of human dendritic cells by recombinant modified vaccinia virus Ankara vectors encoding survivin and IL-2 genes in vitro.
    Tao R; Li L; Huang W; Zheng L
    Hum Gene Ther; 2010 Jan; 21(1):98-108. PubMed ID: 19715401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference with SAMHD1 Restores Late Gene Expression of Modified Vaccinia Virus Ankara in Human Dendritic Cells and Abrogates Type I Interferon Expression.
    Sliva K; Martin J; von Rhein C; Herrmann T; Weyrich A; Toda M; Schnierle BS
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between modified vaccinia virus Ankara and dendritic cells: phenotypic and functional maturation of bystander dendritic cells.
    Pascutti MF; Rodríguez AM; Falivene J; Giavedoni L; Drexler I; Gherardi MM
    J Virol; 2011 Jun; 85(11):5532-45. PubMed ID: 21411535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
    Waibler Z; Anzaghe M; Ludwig H; Akira S; Weiss S; Sutter G; Kalinke U
    J Virol; 2007 Nov; 81(22):12102-10. PubMed ID: 17855554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
    Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing the effects of insertion of a 5.2 kb region of a VACV genome, which contains known immune evasion genes, on MVA immunogenicity.
    Ryerson MR; Shisler JL
    Virus Res; 2018 Feb; 246():55-64. PubMed ID: 29341877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors.
    Zhang X; Cassis-Ghavami F; Eller M; Currier J; Slike BM; Chen X; Tartaglia J; Marovich M; Spearman P
    J Virol; 2007 Jul; 81(13):7022-33. PubMed ID: 17409140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: a potential mechanism for direct presentation.
    Yates NL; Alexander-Miller MA
    Virology; 2007 Mar; 359(2):349-61. PubMed ID: 17056088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression.
    Marín MQ; Pérez P; Gómez CE; Sorzano CÓS; Esteban M; García-Arriaza J
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30096846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine.
    Ramírez JC; Gherardi MM; Esteban M
    J Virol; 2000 Jan; 74(2):923-33. PubMed ID: 10623755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified vaccinia virus Ankara exerts potent immune modulatory activities in a murine model.
    Nörder M; Becker PD; Drexler I; Link C; Erfle V; Guzmán CA
    PLoS One; 2010 Jun; 5(6):e11400. PubMed ID: 20628596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.